Patents by Inventor Takahiro Iwao

Takahiro Iwao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925858
    Abstract: A recording medium and server provide a game that improves the interest in and taste of a battle event and increases the interest in and real enjoyment of the entire game. The recording medium provides a game including a predetermined battle event comprising at least one battle. In a battle event of this game, game contents are displayed in a first field, and a player selects therefrom a game content to be used for a battle with an enemy character. The first field is replenished with another game content alternative to the selected game content as needed so that the player can further select an additional game content therefrom.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: March 12, 2024
    Assignee: GREE, Inc.
    Inventors: Yusuke Hisaoka, Makiko Tamura, Yuji Okada, Takahiro Mori, Mitsuo Iwao
  • Patent number: 11859212
    Abstract: An object of the present invention is to prepare a functional intestinal organoid from pluripotent stem cells. An intestinal organoid is prepared from pluripotent stem cells, by the following steps (1) to (4): (1) differentiating pluripotent stem cells into endoderm-like cells; (2) differentiating the endoderm-like cells obtained in step (1) into intestinal stem cell-like cells; (3) culturing the intestinal stem cell-like cells obtained in step (2) to form spheroids; and (4) differentiating the spheroids formed in step (3) to form an intestinal organoid, the step including culture in the presence of a MEK1/2 inhibitor, a DNA methylation inhibitor, a TGF-? receptor inhibitor, and a ?-secretase inhibitor, in addition to an epidermal growth factor, a BMP inhibitor, and a Wnt signal activator.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: January 2, 2024
    Assignee: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Tamihide Matsunaga, Takahiro Iwao, Daichi Onozato, Isamu Ogawa
  • Patent number: 11725189
    Abstract: It is an object to provide a culture method which is capable of maintaining and/or culturing iPS cell-derived intestinal stem cells, while maintaining the properties of intestinal stem cells. The induced pluripotent stem cell-derived intestinal stem cell-like cells are cultured in the presence of a GSK-3? inhibitor, a histone deacetylation inhibitor, and a serum replacement, or in the presence of a GSK-3? inhibitor and a serum replacement. Preferably, the culture is carried out under conditions in which one or more compounds selected from the group consisting of an epidermal growth factor, a TGF? receptor inhibitor and a fibroblast growth factor are further present.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: August 15, 2023
    Assignees: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, FUJIFILM Corporation
    Inventors: Takahiro Iwao, Tamihide Matsunaga, Satoshi Kondo, Shota Mizuno
  • Patent number: 11499963
    Abstract: An object of the present invention is to provide a novel method which enables convenient preparation of cells exhibiting functions close to that of intestinal epithelial cells of living bodies, and use of the method. The differentiation of induced pluripotent stem cells into intestinal epithelial cells is induced by step of differentiating induced pluripotent stem cells into endoderm-like cells; step of differentiating the endoderm-like cells obtained in step into intestinal stem cell-like cells; and step of differentiating the intestinal stem cell-like cells obtained in step into intestinal epithelial cell-like cells, wherein step includes culture in the presence of a MEK1 inhibitor, a DNA methyltransferase inhibitor, a TGF-? receptor inhibitor, and EGF and under the condition that cAMP is supplied to the cells.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: November 15, 2022
    Assignee: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Takahiro Iwao, Tomoki Kabeya, Tamihide Matsunaga
  • Publication number: 20220033780
    Abstract: An object is to prepare an intestinal organoid having a characteristic close to the small intestine of a living body, from a pluripotent stem cell. An intestinal organoid is prepared from a pluripotent stem cell, by the following steps of: (1) differentiating the pluripotent stem cell into an endoderm-like cell; (2) differentiating the endoderm-like cell obtained in step (1) into an intestinal stem cell-like cell; (3) culturing the intestinal stem cell-like cell obtained in step (2) in the presence of an epidermal growth factor, a fibroblast growth factor, a TGF ? receptor inhibitor, a GSK-3 ? inhibitor, and a ROCK inhibitor; (4) culturing the cell obtained in step (3) to form a spheroid; and (5) differentiating the spheroid formed in step (4) to form an intestinal organoid, wherein the differentiation includes culturing in the presence of an epidermal growth factor, a BMP inhibitor, and a Wnt signal activator.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 3, 2022
    Applicant: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Tamihide MATSUNAGA, Takahiro IWAO, Daichi ONOZATO, Isamu OGAWA
  • Publication number: 20200370020
    Abstract: An object of the present invention is to provide a new means capable of easily and efficiently preparing cells showing a function more similar to the function of intestinal epithelial cells of a living body. According to the present invention, pluripotent stem cells are induced to differentiate into intestinal stem cell-like cells by a method for inducing differentiation of pluripotent stem cells into intestinal epithelial cells, the method including a step (1) of differentiating pluripotent stem, cells into intestinal stem cell-like cells and a step (2) of differentiating the intestinal stem cell-like cells obtained in the step (1) into intestinal epithelial cell-like cells by using an MEK1 inhibitor, a DNA methylation inhibitor, a TGF? receptor inhibitor, EGF, and a cAMP activator in combination.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Applicants: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, FUJIFILM Corporation
    Inventors: Tamihide MATSUNAGA, Takahiro Iwao, Tomoki Kabeya, Shinji Mima, Toshihide Miyashita
  • Publication number: 20200157507
    Abstract: An object of the present invention is to prepare a functional intestinal organoid from pluripotent stem cells. An intestinal organoid is prepared from pluripotent stem cells, by the following steps (1) to (4): (1) differentiating pluripotent stem cells into endoderm-like cells; (2) differentiating the endoderm-like cells obtained in step (1) into intestinal stem cell-like cells; (3) culturing the intestinal stem cell-like cells obtained in step (2) to form spheroids; and (4) differentiating the spheroids formed in step (3) to form an intestinal organoid, the step including culture in the presence of a MEK1/2 inhibitor, a DNA methylation inhibitor, a TGF-? receptor inhibitor, and a ?-secretase inhibitor, in addition to an epidermal growth factor, a BMP inhibitor, and a Wnt signal activator.
    Type: Application
    Filed: May 2, 2018
    Publication date: May 21, 2020
    Inventors: Tamihide Matsunaga, Takahiro Iwao, Daichi Onozato, Isamu Ogawa
  • Publication number: 20200040294
    Abstract: There are provided a device and a method for more appropriate evaluation of a chemical substance. The device for the evaluation of the chemical substance includes a first compartment, and a second compartment that communicates with the first compartment and is separated from the first compartment by a partition wall.
    Type: Application
    Filed: January 18, 2018
    Publication date: February 6, 2020
    Inventors: TAMIHIDE MATSUNAGA, Takahiro IWAO, Satoshi KONDO, Atsushi DOI, Isao SAITO
  • Publication number: 20200002680
    Abstract: It is an object to provide a culture method which is capable of maintaining and/or culturing iPS cell-derived intestinal stem cells, while maintaining the properties of intestinal stem cells. The induced pluripotent stem cell-derived intestinal stem cell-like cells are cultured in the presence of a GSK-3? inhibitor, a histone deacetylation inhibitor, and a serum replacement, or in the presence of a GSK-3? inhibitor and a serum replacement. Preferably, the culture is carried out under conditions in which one or more compounds selected from the group consisting of an epidermal growth factor, a TGF? receptor inhibitor and a fibroblast growth factor are further present.
    Type: Application
    Filed: August 20, 2019
    Publication date: January 2, 2020
    Applicants: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, FUJIFILM Corporation
    Inventors: Takahiro IWAO, Tamihide Matsunaga, Satoshi Kondo, Shota Mizuno
  • Publication number: 20190079076
    Abstract: An object of the present invention is to provide a novel method which enables convenient preparation of cells exhibiting functions close to that of intestinal epithelial cells of living bodies, and use of the method. The differentiation of induced pluripotent stem cells into intestinal epithelial cells is induced by step of differentiating induced pluripotent stem cells into endoderm-like cells; step of differentiating the endoderm-like cells obtained in step into intestinal stem cell-like cells; and step of differentiating the intestinal stem cell-like cells obtained in step into intestinal epithelial cell-like cells, wherein step includes culture in the presence of a MEK1 inhibitor, a DNA methyltransferase inhibitor, a TGF-? receptor inhibitor, and EGF and under the condition that cAMP is supplied to the cells.
    Type: Application
    Filed: March 3, 2017
    Publication date: March 14, 2019
    Inventors: Takahiro Iwao, Tomoki Kabeya, Tamihide Matsunaga